Healthcare - Biotechnology - NASDAQ - US
$ 19.0
-5.8 %
$ 578 M
Market Cap
-3.23
P/E
Price Target
Average
184.96%
Revenue Forecast
Estimate
56.36%
EBIT
Estimate
15.02%
Net Income
Estimate
--0.93%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
AnaptysBio, Inc.
Wall Street analysts predict an average 1-year price target for ANAB of $54.1 , with forecasts ranging from a low of $30 to a high of $90 .
ANAB Lowest Price Target
Wall Street Target
30 USD
57.89%
ANAB Average Price Target
Wall Street Target
54.1 USD
184.96%
ANAB Highest Price Target
Wall Street Target
90 USD
373.68%
REVENUE FORECAST
Revenue Forecast Chart ANAB
EBIT FORECAST
EBIT Forecast Chart ANAB
NET INCOME FORECAST
Net Income Chart ANAB